Skip to content
AnalystLens

Corteva, Inc. Annual Report, Year Ended Dec 31, 2025

Filing Date
Filed February 12, 2026
Period End
December 31, 2025
Security
CTVA
In the record · 2019–202610-K710-Q238-K85

CTVA filed 7 annual reports (10-K), 23 quarterly reports (10-Q) and 85 current reports (8-K) between 2019 and 2026.

  1. Leadership change8-K · Feb ’21Feb ’21
  2. Restructuring8-K · Aug ’22Aug ’22
  3. Impairment8-K · Nov ’23Nov ’23
  4. Leadership change8-K · Oct ’26Oct ’26

Summary

Summary of the 10-K filed February 12, 2026. Cited figures are marked; the original filing is the authoritative source.

Corteva, Inc. reported robust performance for the year ended December 31, 2025, with net sales increasing by 3% to $17.4 billiona, driven by a 1% rise in price and a 3% increase in volume.

This growth was achieved despite a 1% unfavorable currency impact. The company demonstrated strong operational execution, with Cost of Goods Sold (COGS) decreasing to $9.2 billionb due to cost-saving initiatives, raw material deflation, and lower commodity prices, partially offset by higher volumes. Income from continuing operations after taxes significantly improved to $1.2 billion from $863 million in the prior year, with Operating EBITDA rising to $3.8 billion from $3.4 billion.

Key strategic priorities for Corteva include delivering top-tier technology, increasing market share in seed trait out-licensing, driving operational improvements, and completing the intended separation of its Seed and Crop Protection businesses into two standalone public companies by the second half of 2026. The company also returned approximately $1.5 billionc to shareholders through share repurchases and dividends in 2025, underscoring its commitment to shareholder value. Corteva remains focused on innovation and deploying capital with discipline to drive organic and inorganic growth.

Key Highlights

  1. Net sales increased 3% year-over-year to $17.4 billion, driven by a 1% price increase and 3% volume increase.
  2. Income from continuing operations after taxes significantly improved to $1.2 billion, a substantial increase from $863 million in the prior year.
  3. Operating EBITDA grew by 14% to $3.8 billion, reflecting operational efficiencies and volume growth.
  4. The company returned approximately $1.5 billion to shareholders through share repurchases and dividends in 2025.
  5. Corteva announced its intent to separate its Seed and Crop Protection businesses into two independent publicly traded companies, expected to be completed in the second half of 2026.
  6. Investment in Research and Development increased to $1.5 billion, supporting the company's innovation pipeline.
  7. Selling, General, and Administrative (SG&A) expenses as a percentage of net sales increased slightly to 20% from 19%.

Financial Statements

FY2025 against FY2024

Line itemFY2025FY2024Change
Revenue$17.40B$16.91B+2.9%
Cost of Revenue$9.17B$9.53B−3.7%
Gross Profit$8.23B$7.38B+11.5%
R&D Expenses$1.47B$1.40B+5.1%
SG&A Expenses$3.49B$3.20B+9.3%
Net Income$1.10B$919.00M+20.2%
EPS (Basic)$1.60$1.31+22.1%
EPS (Diluted)$1.60$1.30+23.1%
Shares Outstanding (Basic)680.00M693.70M−2.0%
Shares Outstanding (Diluted)681.40M696.00M−2.1%

Frequently Asked Questions

  1. What were Corteva's key financial performance indicators for the year ended December 31, 2025?

    Corteva reported net sales of $17.4 billion, an increase of 3% compared to the prior year. Income from continuing operations after taxes was $1.2 billion, and Operating EBITDA was $3.8 billion, up 14% year-over-year. The company also repurchased shares and paid dividends totaling approximately $1.5 billion.

  2. What are Corteva's main strategic priorities moving forward?

    Corteva's primary strategic priorities include focusing on the delivery of technology in core markets, increasing seed trait out-licensing, driving operational improvements for cost and productivity benefits, and completing the planned separation of its Seed and Crop Protection businesses into two standalone companies by the second half of 2026. The company also aims to deploy capital with discipline for organic and inorganic growth and shareholder returns.

  3. What significant corporate actions did Corteva announce or undertake in 2025?

    The most significant corporate development was the announcement of Corteva's intent to separate its Seed and Crop Protection businesses into two independent publicly traded companies. This strategic move is expected to unlock further value and allow each business to focus on its distinct growth opportunities. Additionally, the company continued its share repurchase program and increased its quarterly dividend.